IP Library › Assignment 063820/0657
Patent Assignment
Reel/Frame 063820/0657

Assignment of Assignor's Interest

Recorded: 2023-06-01 Pages: 4
Assignor
CASCADIAN THERAPEUTICS, INC.
Executed: 2019-09-17
Assignee
SEATTLE GENETICS, INC.
21823 30TH DR. SE, BOTHELL, WASHINGTON, 98021
Covered Property (1)
Treatment of HER2 Positive Cancers
Application: 18/139,653 →
Publication: US 2023/0390290
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 1, 2023
From: PETERSON, SCOTT; WALKER, LUKE
To: CASCADIAN THERAPEUTICS, INC.
Reel/Frame 063820/0618 →
Change of Name Jun 1, 2023
From: SEATTLE GENETICS, INC.
To: SEAGEN INC.
Reel/Frame 063821/0793 →